Biomarin Pharmaceutical Inc (BMRN)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 6,988,940 | 6,841,600 | 6,375,070 | 6,004,770 | 5,848,020 |
| Total stockholders’ equity | US$ in thousands | 5,657,990 | 4,951,550 | 4,603,160 | 4,265,670 | 4,100,930 |
| Financial leverage ratio | 1.24 | 1.38 | 1.38 | 1.41 | 1.43 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $6,988,940K ÷ $5,657,990K
= 1.24
The financial leverage ratio of Biomarin Pharmaceutical Inc has been gradually decreasing over the last five years, indicating improved financial stability. As of December 31, 2020, the ratio stood at 1.43 and decreased to 1.41 by the end of 2021, further declining to 1.38 for both 2022 and 2023. The most significant drop occurred in the most recent year, with the ratio reaching 1.24 as of December 31, 2024. This trend suggests that the company has been reducing its reliance on debt financing relative to equity, which can positively impact its overall financial health and risk profile.
Peer comparison
Dec 31, 2024